Free Cash Flow

Illinois Tool Works reaffirms its 'Dividend King' status with a new payout, signaling robust financial health and confidence in the industrial sector's recovery.

Swedish mining giant Boliden lands a massive €1 billion credit line, signaling strong bank confidence and fueling its expansion after a landmark year.

The biotech firm enacts a 1-for-25 stock split to avoid delisting, placing its promising cancer therapy pipeline under a brighter, more critical spotlight.

The Canadian restaurant giant defied a tough market in 2025, posting record sales and boosting investor payouts through strategic promotions and delivery.

A Taiwanese whisky distributor is betting big on AI with $120M in proposed deals, raising questions of genius, risk, and the frenzy of the AI gold rush.

The pipeline giant's record $20B EBITDA is fueled by traditional energy, while it aggressively expands into renewables to power the digital economy.

Magna beat Q4 expectations and raised its dividend, but a $591M tech impairment and looming Ford recall costs paint a complex picture for the auto giant.

Legrand's plan to repurchase 250,000 shares goes beyond pure financials, signaling a strategic investment in its workforce amid a competitive market.

Tucows announced a new $40M stock buyback, but investor concerns over its strategic pivot and debt overshadow the move, pushing shares lower.

The aviation firm renews its share buyback program, a move backed by a stronger balance sheet and a strategic pivot to higher-margin services.

Weatherford deepens its partnership with TotalEnergies, landing a crucial multi-year deal to support Denmark's offshore energy infrastructure.

With massive data center orders but cautious guidance, the industrial giant's upcoming conference talks are a key test of investor confidence.

With revolutionary tech and a volatile stock, PureCycle's year-end update is a critical test of its operational progress and financial promises.

Twilio reports a landmark year of GAAP profitability and robust growth, signaling a strategic pivot to AI as it guides for a billion in 2026 cash flow.

Despite Q4 headwinds, the auto supplier's massive EV wins and deep focus on China fuel an ambitious 2026 forecast for double-digit profitability.

Aethlon Medical advances its Hemopurifier for oncology and Long COVID, but a shrinking cash reserve and rising quarterly loss test its lean science strategy.

As Liberty Latin America preps its 2025 results, investors watch to see if strong subscriber growth and cost-cutting can sustain momentum in a competitive market.

The pet insurance giant swung to a major profit in 2025, but a closer look reveals a complex strategy of focused growth and rising acquisition costs.

Investors eye Globus Medical's upcoming report for a full-year look at its NuVasive integration, market trends, and a pivotal 2025 performance.

The streaming pioneer smashed Q4 estimates and returned to full-year profitability, signaling a strong 2026 with ambitious growth targets for its ad platform.